Lopinavir
- Molecular formula
- C37H48F2N2O5
- CAS Number
- 192725-17-0
- IUPAC Name
- tert-butyl 2-[2-[[2-(3,5-difluorophenyl)acetyl]amino]propanoylamino]-2-phenyl-acetate
- Molecular Weight
- 628.81g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.2500g/cm3
- Synonyms
- (3, 5-Difluorophenylacetyl)-Ala-Phg-OtBu
Identification
Interesting Facts About Tert-butyl 2-[2-[[2-(3,5-difluorophenyl)acetyl]amino]propanoylamino]-2-phenyl-acetate
As a compound of significant interest in the world of medicinal chemistry, tert-butyl 2-[2-[[2-(3,5-difluorophenyl)acetyl]amino]propanoylamino]-2-phenyl-acetate offers a variety of intriguing characteristics:
- Pharmaceutical Relevance: This compound showcases potential therapeutic applications, particularly due to its functional groups that can interact with various biological targets.
- Fluorinated Phenyl Ring: The presence of 3,5-difluorophenyl moiety is crucial, as fluorination often enhances pharmacological properties and increases metabolic stability.
- Amide Bond Significance: The amide bond in the structure is a common motif in medicinal chemistry, contributing to the compound's biological activity and potential efficacy as a drug.
- Structural Complexity: With multiple interconnected rings and functional groups, this compound is an excellent example of how structural complexity can lead to enhanced interactions with biological systems.
This compound exemplifies the exciting intersection of structure and function in drug design. As researchers continue to explore such compounds, they hold promise for developing new treatments and enhancing existing therapies. In the words of a well-known chemist, "Chemistry is the design of matter, and this compound is a testament to the creative possibilities inherent in the field."
Overall, understanding the properties and potential applications of tert-butyl 2-[2-[[2-(3,5-difluorophenyl)acetyl]amino]propanoylamino]-2-phenyl-acetate greatly expands our knowledge in medicinal chemistry and opens doors for future innovations.